Charles W. Newton - Apr 25, 2025 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/ Mark J. Casey, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Apr 25, 2025
Transactions value $
$0
Form type
4
Date filed
4/29/2025, 08:08 AM
Previous filing
Mar 18, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Stock Option (Right to buy) Award $0 +42.8K $0.00 42.8K Apr 25, 2025 Common Stock 42.8K $6.70 Direct F1
transaction NVAX Restricted Stock Units Award $0 +28.6K $0.00 28.6K Apr 25, 2025 Common Stock 28.6K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest with respect to one-third (1/3) of the shares on each of the first three (3) anniversaries of the April 25, 2025 grant date (the "Grant Date"), in each case subject to continued service on the Company's Board of Directors through such vesting date.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F3 The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued service on the Company's Board of Directors through such vesting date.